These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14250654)

  • 1. PREVENTION OF ANTILEUKEMIC EFFECT OF TEREPHTHALANILIDE DERIVATIVES IN TRANSPLANTED MOUSE LEUKEMIA P815 BY 4,4'-(TEREPHTHALOYLDIIMINO)DIBENZENESULFONIC ACID DISODIUM SALT (NSC-55156).
    BURCHENAL JH; PURPLE JR; SPOONER EB; BERCHTOLD R; HIRT R; FISCHER R; BALSIGER R
    Cancer Chemother Rep; 1964 Dec; 43():5-10. PubMed ID: 14250654
    [No Abstract]   [Full Text] [Related]  

  • 2. PREVENTION BY SULFONIC AND PHOSPHORIC ANALOGS OF THE TEREPHTHALANILIDE INHIBITION OF LEUKEMIA P815Y IN VITRO.
    BURCHENAL JH; GREGG VC; LANCASTER SP; HIRT R; BERCHTOLD R; FISCHER R; BALSIGER R
    Cancer Res; 1965 May; 25():469-71. PubMed ID: 14297483
    [No Abstract]   [Full Text] [Related]  

  • 3. SEARCH FOR METABOLITES OF ANTILEUKEMIC PHTHALANILIDES, 2-CHLORO-4',4"-DI-2-IMIDAZOLIN-2-YLTEREPHTHALANILIDE (NSC-60339) AND 2-AMINO-4',-4"-DI-2-IMIDAZOLIN-2-YLTEREPHTHALANILIDE DIHYDROCHLORIDE (NSC-50469).
    BOOTH J; BOYLAND E; GELLHORN A
    Cancer Chemother Rep; 1964 Dec; 43():11-8. PubMed ID: 14250645
    [No Abstract]   [Full Text] [Related]  

  • 4. DISTRIBUTION AND EFFECTS OF 4', 4"-DI(2-IMIDAZOLIN-2-YL)TEREPHTHALANILIDE DIHYDROCHLORIDE HEMIHYDRATE AND ITS 2-CHLORO ANALOGUE IN LYMPHOCYTIC LEUKEMIAS L1210 AND P388.
    SIVAK A; ROGERS WI; WODINSKY I; KENSLER CJ
    J Natl Cancer Inst; 1964 Sep; 33():457-65. PubMed ID: 14207856
    [No Abstract]   [Full Text] [Related]  

  • 5. EXTRACTION AND FLUOROMETRIC DETERMINATION OF A TEREPHTHALANILIDE IN BIOLOGICAL TISSUES.
    CHIRIGOS MA; VENDITTI JM; FANNING GR
    Cancer Chemother Rep; 1963 Oct; 32():1-5. PubMed ID: 14088831
    [No Abstract]   [Full Text] [Related]  

  • 6. LACK OF CROSS RESISTANCE TO THE AMIDINO AND THE UREIDO DERIVATIVES IN MOUSE LEUKEMIAS MADE RESISTANT TO 4',4"-BIS(2-IMIDAZOLIN-2-YL)-2-CHLOROTEREPHTHALANILIDE DIHYDROCHLORIDE (NSC 38280).
    BURCHENAL JH; LYMAN MS
    Proc Can Cancer Conf; 1963; 5():439-48. PubMed ID: 14278873
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES ON THE MECHANISMS OF ACTION OF VARIOUS PHTHALANILIDE DERIVATIVES BY CROSS-RESISTANCE AND TISSUE CULTURE.
    BURCHENAL JH; COLEY V; PURPLE JR; BUCHOLZ E; LYMAN MS; KREIS W
    Cancer Res; 1963 Sep; 23():1364-74. PubMed ID: 14070390
    [No Abstract]   [Full Text] [Related]  

  • 8. CELL SURFACE EFFECTS OF A PHTHALANILIDE DERIVATIVE.
    VASSAR PS; SANNE WL
    J Pharm Sci; 1964 Oct; 53():1285. PubMed ID: 14249468
    [No Abstract]   [Full Text] [Related]  

  • 9. THE EFFECT OF A PHTHALANILIDE DERIVATIVE ON LIPIDE METABOLISM IN L1210 LEUKEMIA CELLS.
    GELLHORN A; WAGNER M; RECHLER M; KOREN Z; BENJAMIN W
    Cancer Res; 1964 Apr; 24():400-8. PubMed ID: 14147813
    [No Abstract]   [Full Text] [Related]  

  • 10. PHYSIOLOGIC DISPOSITION STUDIES OF SOME SUBSTITUTED PHTHALANILIDES.
    ROGERS WI; SIVAK A; KENSLER CJ
    Cancer Chemother Rep; 1964 May; 38():9-16. PubMed ID: 14167471
    [No Abstract]   [Full Text] [Related]  

  • 11. THE TREATMENT OF EXPERIMENTAL MOUSE HEMOBLASTOSIS. I. THE EFFECT OF SOME NEW FOLIC ACID ANTIMETABOLITES ON CELL TRANSPLANTED LEUKEMIA IN MICE OF THE AKR STRAIN.
    MOTYCKA K; SOUCEK J; SLAVIK K; JIRASEK J; JIRASEK A
    Neoplasma; 1964; 11():389-97. PubMed ID: 14200027
    [No Abstract]   [Full Text] [Related]  

  • 12. ANTILEUKEMIC ACTIVITY OF HYDROXYUREA (NSC-32065) AND OTHER UREA DERIVATIVES.
    GOLDIN A; VENDITTI JM; MEAD JA; GLYNN JP
    Cancer Chemother Rep; 1964 Aug; 40():57-74. PubMed ID: 14206921
    [No Abstract]   [Full Text] [Related]  

  • 13. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS.
    BURCHENAL JH; OETTGEN HF; LYMAN M; PURPLE J
    Acta Unio Int Contra Cancrum; 1964; 20():256-9. PubMed ID: 14151900
    [No Abstract]   [Full Text] [Related]  

  • 14. CARCINOGENIC ACTIVITY OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213).
    KELLY MG; O'GARA RW; GADEKAR K; YANCEY ST; OLIVERIO VT
    Cancer Chemother Rep; 1964 Jul; 39():77-80. PubMed ID: 14201279
    [No Abstract]   [Full Text] [Related]  

  • 15. CHEMOTHERAPEUTIC ACTIVITY OF PHTHALANILIDE DERIVATIVES. AN APPROACH TO ANTICODIC THERAPY?
    KENSLER CJ
    Cancer Res; 1963 Sep; 23():1353-63. PubMed ID: 14070389
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo studies of the antileukemic action of n,n'-bos [p-(n'-methylamidino)phenyl]terephthalamidine, tetrahydrochloride (NSC 57155) on P815 leukemic cells.
    Winkler A; Kreis W; Gregg VC; Purple JR; Burchenal JH
    Cancer Res; 1966 Jul; 26(7):1502-7. PubMed ID: 5916484
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of phthalanilide-lipid complexes to uptake and retention of 2-chloro-4',4"-di(2-imidazolin-2-yl)terephthalanilide (NSC 60339) by sensitive and resistant P388 leukemia cells.
    Yesair DW; Kohner FA; Rogers WI; Baronowsky PE; Kensler CJ
    Cancer Res; 1966 Feb; 26(2):202-7. PubMed ID: 5903172
    [No Abstract]   [Full Text] [Related]  

  • 18. EVALUATION OF ANTILEUKEMIC AGENTS EMPLOYING ADVANCED LEUKEMIA L1210 IN MICE. VII.
    VENDIITI JM; SHELDON DR; GOLDIN A
    Cancer Res; 1964 Jan; 24():145-96. PubMed ID: 14106543
    [No Abstract]   [Full Text] [Related]  

  • 19. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 20. EFFECT OF ADMINISTRATION OF THE ENZYME GLUTAMINASE ON THE GROWTH OF CANCER CELLS.
    GREENBERG DM; BLUMENTHAL G; RAMADAN ME
    Cancer Res; 1964 Jul; 24():957-63. PubMed ID: 14195348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.